ZP Therapeutics
The go-to commercialisation partner for the healthcare industry, and a valued partner in providing innovations to the healthcare community and expanding patient access. ZP Therapeutics is the partner of choice for companies looking for a sales and marketing partner in Asia.
See below for the Latest ZP Therapeutics News, Analysis, Profit Results, Share Price Information, and Commentary.
ZP Therapeutics bagged Healthcare Asia Pharma Awards 2024 for continuing medical education
ZP Therapeutics bagged Healthcare Asia Pharma Awards 2024 for continuing medical education
It has engaged global medical experts and opinion makers to set up medical education events.
ZP Therapeutics earns dual accolades at the Healthcare Asia Pharma Awards
The commercialisation division of Zuellig Pharma claims the Most Differentiated Service of the Year and Outcomes-based Contracting Model of the Year titles.
Most Read
1. Hong Kong seeks prescription for nursing shortage 2. ASEAN medical tourism set to outpace global revenue growth 3. OUE Healthcare subsidiary secures majority stake in Rehab Matters 4. Thomson and Monash University Malaysia partner for joint research 5. Sunway Medical Centre Ipoh to open in Q2 2025Resource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
The trade show, which was held in Singapore, successfully brought together over 13,000 visionary digital health innovators, government leaders, and industry pioneers from the medical and healthcare sectors.
